Sonoma Pharmaceuticals
SNOA
$0.16
Share price
2.03%
Change (1 day)
-83.57%
Change (1 year)
Categories
Operating Margin for Sonoma Pharmaceuticals (SNOA)
Operating Margin as of May 2024 (TTM): -42.90%
According to Sonoma Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -42.90%. At the end of 2022 the company had an Operating Margin of -42.90%.
Operating Margin history for Sonoma Pharmaceuticals from 2004 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -42.90% | 104.84% |
| 2021 | -20.95% | 40.4% |
| 2020 | -14.92% | -75.04% |
| 2019 | -59.78% | -30.5% |
| 2018 | -86.01% | -14.73% |
| 2017 | -100.87% | 49.73% |
| 2016 | -67.37% | 13.78% |
| 2015 | -59.21% | -316.68% |
| 2014 | 27.33% | -177.75% |
| 2013 | -35.15% | -30.74% |
| 2012 | -50.75% | -34.05% |
| 2011 | -76.94% | -29.32% |
| 2010 | -108.85% | -66.11% |
| 2009 | -321.21% | -45.07% |
| 2008 | -584.75% | 36.34% |
| 2007 | -428.88% | -46.85% |
| 2006 | -806.93% | -32.92% |
| 2005 | -1,202.95% | -1302.95% |
| 2004 | 100.00% | -268.26% |
| 2003 | -59.43% | 708.61% |
| 2002 | -7.35% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -15.24% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 19,459.79% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.